▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2918 by analyst upside · 2026-09-27
OSCR
Oscar Health, Inc.
Healthcare · Market Cap $9B · P/E 22.8x
ANALYST PRICE TARGET
+19.6%
implied upside to consensus target
Current Price $29.6
Consensus Target $35.4
Bull Target $49.0
Bear Target $26.0
Analysts Covering 10
ANALYST CONSENSUS - BUY
Strong Buy
3
Buy
0
Hold
6
Sell
1
52-Week Low $10.69
52-Week High $34.48
YTD Return +97.7%
FUNDAMENTALS
Market Cap $9B
P/E Ratio (TTM) 22.8x
Forward P/E 13.7x
EPS (TTM) $1.30
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $15.3B
Profit Margin 3.6%
52-WEEK RANGE
52-Week Low $10.69
52-Week High $34.48
Current Price $29.6
Bear Target $26.0
Bull Target $49.0
● Now $29.6 ● Target $35.4
TRADING DATA
Avg Volume 5.4M
YTD Return +97.7%
Analyst Count 10
Consensus Buy
Upside to Target +19.6%
Last Updated 2026-09-27

ANALYST SUMMARY

Oscar Health, Inc. (OSCR) is currently trading at $29.6 with a Wall Street consensus price target of $35.4, implying potential upside of 19.6% over the next 12 months. 10 analysts currently cover OSCR, with a consensus rating of Buy - 30% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $49.0, while the most cautious has a target of $26.0.

OSCR operates in the Healthcare sector with a market capitalisation of $9B. The stock is up 97.7% year-to-date and is currently trading near the upper end of its 52-week range of $10.69 – $34.48.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for OSCR, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Raymond James - Reiterated
Outperform → Outperform 2026-09-18 Building track record
B of A Securities - Reiterated
Underperform → Underperform 2026-09-17 Building track record
Stephens & Co. reit
Equal-Weight → Equal-Weight 2026-09-17 Building track record
Barclays - Reiterated
Overweight → Overweight 2026-09-17 Building track record
Baird - Reiterated
Neutral → Neutral 2026-09-17 Building track record
Wells Fargo - Reiterated
Equal-Weight → Equal-Weight 2026-08-13 Building track record
UBS - Reiterated
Neutral → Neutral 2026-08-07 33% win rate (6 calls)
Barclays - Reiterated
Overweight → Overweight 2026-08-07 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
34
out of 100
Coverage depth
18/30
Consensus clarity
14/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →